Format

Send to

Choose Destination
See comment in PubMed Commons below
J Allergy Clin Immunol. 2014 Feb;133(2):560-7. doi: 10.1016/j.jaci.2013.06.011. Epub 2013 Aug 6.

Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration.

Author information

  • 1Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • 2Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • 3University Hospital Basel, University of Basel, Basel, Switzerland.
  • 4Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie du Quebec, Université Laval, Quebec City, Quebec, Canada.
  • 5Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: gounni@cc.umanitoba.ca.

Abstract

BACKGROUND:

Chronic airway diseases, including asthma, are characterized by increased airway smooth muscle (ASM) mass that is due in part to growth factor-mediated ASM cell proliferation and migration. However, the molecular mechanisms underlying these effects are not completely understood. Semaphorin 3E (Sema3E) has emerged as an essential mediator involved in cell migration, proliferation, and angiogenesis, although its role in ASM cell function is not investigated.

OBJECTIVES:

We sought to determine the expression of Sema3E receptor, plexinD1, in human ASM cells (HASMCs); effect of Sema3E on basal and platelet-derived growth factor (PDGF)-induced proliferation and migration; and underlying signaling pathways.

METHODS:

Expression of plexinD1 in HASMCs was studied with RT-PCR, immunostaining, and flow cytometry. The effect of Sema3E on HASMC proliferation and migration was evaluated by 5-ethynyl-2'-deoxyuridine (EdU) incorporation, cell count, and Boyden chamber assay. Sema3E-mediated intracellular signaling was investigated with fluorescent microscopy, flow cytometry, Rac1 activation, and Western blot analysis.

RESULTS:

HASMCs from healthy persons expressed plexinD1 more than HASMCs from asthmatic patients. Sema3E increased plexinD1 expression in HASMCs from asthmatic patients. Recombinant Sema3E inhibited PDGF-mediated HASMC proliferation and migration, which was associated with F-actin depolymerization, suppression of PDGF-induced Rac1 guanosine triphosphatase activity, and Akt and extracellular signal-regulated kinase 1 and 2 phosphorylation. Bronchial biopsies from patients with mild asthma displayed immunoreactivity of plexinD1, suggesting the potential in vivo role of Sema3E-PlexinD1 axis in HASMC function.

CONCLUSION:

This study provides the first evidence that Sema3E receptor is expressed and plays functional roles in HASMCs. Our data suggest a regulatory role of Sema3E in PDGF-mediated proliferation and migration, leading to downregulation of ASM remodeling.

Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

KEYWORDS:

5-Ethynyl-2′-deoxyuridine; ASM; Airway smooth muscle; Airway smooth muscle cell; EGF; ERK; EdU; Epidermal growth factor; Extracellular signal-regulated kinase; FACS; Fluorescence-activated cell sorting; GTPase; Guanosine triphosphatase; HASMC; Human airway smooth muscle cell; MAPK; MFI; Mean fluorescence intensity; Mitogen-activated protein kinase; PDGF; PI3K; Phosphatidylinositol 3-kinase; Platelet-derived growth factor; Rac1; Ras-related C3 botulinum toxin substrate 1; Sema3E; Semaphorin 3E; VEGFR2; Vascular endothelial growth factor receptor 2; migration; platelet-derived growth factor; plexinD1; proliferation; semaphorin 3E

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk